Chappell Ava G, Spinner Robert J, Bishop Allen T, Shin Alexander Y
Division of Hand Surgery, Department of Orthopedic Surgery, Mayo Clinic, Rochester, MN, USA.
Department of Neurosurgery, Mayo Clinic, Rochester, MN, USA.
J Hand Surg Am. 2025 Jul;50(7):890.e1-890.e9. doi: 10.1016/j.jhsa.2024.06.010. Epub 2024 Aug 9.
Hirayama disease (HD) is a rare, nonfamilial, self-limiting, progressive lower cervical myelopathy, resulting in debilitating distal upper-extremity motor deficits, mimicking high ulnar neuropathy, lower trunk brachial plexopathy, or C8-T1 radiculopathy. Although most literature focuses on pathophysiology and prevention of disease progression, there remains limited discussion regarding treatment to improve upper-extremity function in patients with stable disease. The upper-extremity manifestations of HD are reviewed along with surgical options for restoring hand function.
A retrospective review of patients with HD who underwent reconstruction to improve hand function was undertaken. Demographic data, preoperative electrodiagnostic and electromyographic, and physical examination findings were collected. Outcome data involved postoperative grip, pinch, and functional assessment documented on clinical visits. Qualitative descriptions of the surgical techniques are described.
Among six patients identified, four met the inclusion criteria and underwent tendon transfers and selected joint arthrodeses. All patients were diagnosed as teenagers, were right hand-dominant, and three were male. Unilateral symptoms were present in one patient and were bilateral in the rest. All patients were treated with tendon transfers for thumb opposition, grasp, anticlaw, and thumb interphalangeal joint arthrodesis. All patients had postoperative grip strength improvement. The average follow-up was 3.2 years.
Hirayama disease is a rare disease often managed by spine surgeons and neurologists who may be unaware of options for restoring hand function deficits. Technical strategies and outcomes of improving hand function in HD have not been adequately described. Surgical options to improve hand function are tailored to the deficits and include tendon transfers, select joint arthrodeses, and/or tenodeses. Risk of disease progression and expectations following hand reconstruction must be managed carefully.
Therapeutic V.
平山病(HD)是一种罕见的、非家族性的、自限性的、进行性下颈段脊髓病,可导致使人衰弱的上肢远端运动功能障碍,类似高位尺神经病变、下干臂丛神经病变或C8 - T1神经根病。尽管大多数文献关注疾病的病理生理学和疾病进展的预防,但关于改善病情稳定患者上肢功能的治疗方法的讨论仍然有限。本文回顾了平山病的上肢表现以及恢复手部功能的手术选择。
对接受重建手术以改善手部功能的平山病患者进行回顾性研究。收集了人口统计学数据、术前电诊断和肌电图以及体格检查结果。结果数据包括临床就诊时记录的术后握力、捏力和功能评估。描述了手术技术的定性描述。
在确定的6例患者中,4例符合纳入标准并接受了肌腱转移和选择性关节融合术。所有患者均在青少年时期被诊断,以右手为主,3例为男性。1例患者为单侧症状,其余为双侧症状。所有患者均接受了肌腱转移手术,用于拇指对掌、抓握、抗爪形手以及拇指指间关节融合术。所有患者术后握力均有改善。平均随访时间为3.2年。
平山病是一种罕见疾病,脊柱外科医生和神经科医生通常负责其治疗,但他们可能并不了解恢复手部功能障碍的治疗方法。平山病改善手部功能的技术策略和结果尚未得到充分描述。改善手部功能的手术选择是根据功能障碍量身定制的,包括肌腱转移、选择性关节融合术和/或肌腱固定术。必须谨慎处理疾病进展的风险以及手部重建后的预期效果。
研究类型 证据水平:治疗性V级